Valeo Pharmainc (VPH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 07-2019 | 04-2019 | 01-2019 | 10-2018 | 07-2018 | |
| Sales | 2,601 | 1,010 | 1,832 | 1,750 | 2,111 |
| Cost of Goods | 1,689 | 863 | 1,546 | 1,604 | 1,677 |
| Gross Profit | 912 | 147 | 286 | 146 | 434 |
| Operating Expenses | 1,165 | 1,300 | 1,268 | 1,084 | 732 |
| Operating Income | -253 | -1,153 | -982 | -938 | -298 |
| Interest Expense | 18 | 21 | 34 | 24 | 52 |
| Other Income | 9 | 33 | 28 | 33 | 20 |
| Pre-tax Income | -262 | -1,141 | -989 | -929 | -330 |
| Income Tax | 0 | 0 | 0 | 0 | -5 |
| Net Income Continuous | -262 | -1,141 | -989 | -929 | -325 |
| Net Income | $-262 | $-1,141 | $-989 | $-929 | $-325 |
| EPS Basic Total Ops | -0.01 | -0.03 | -0.02 | -0.02 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.03 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.01 | -0.03 | -0.02 | -0.02 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.03 | N/A | N/A | N/A |
| EBITDA(a) | $-219 | $-1,107 | $-942 | $-892 | $-266 |